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Abstract
Increasing hospital admissions for pneumonia have been reported recently but it is not known
whether pneumonia incidence rates have increased in the community. To determine whether
incidence rates of pneumonia increased in primary care in the United Kingdom from 2002 to
2017, an open cohort study was conducted using electronic health records from the UK
Clinical Practice Research Datalink. Clinically diagnosed pneumonia, influenza pneumonia,
pleural infection and clinically suspected pneumonia, defined as chest infection treated
with antibiotics, were evaluated. Age-standardised and age-specific rates were estimated.
Joinpoint regression models were fitted and annual percentage changes (APC) were estimated.
There were 70.7 million person-years of follow-up with 120 662 episodes of clinically diag-
nosed pneumonia, 1 831 005 of clinically suspected pneumonia, 23 814 episodes of influenza
pneumonia and 2644 pleural infections over 16 years. The incidence of clinically diagnosed
pneumonia increased from 1.50 per 1000 person-years in 2002 to 2.22 per 1000 in 2017.
From 2010 to 2017, the APC in age-standardised incidence was 5.1% (95% confidence interval
3.4–6.9) compared with 0.3% (−0.6 to 1.2%) before 2010. Clinically suspected pneumonia
incidence rates increased from 2002 to 2008 with an APC 3.8% (0.8–6.9) but decreased
with an APC −4.9% (−6.7 to −3.1) from 2009 to 2017. Influenza pneumonia increased in
the epidemic year of 2009. There was no overall trend in pleural infection. The results
show that clinically diagnosed pneumonia has increased in primary care but there was a con-
temporaneous decline in recording of clinically suspected pneumonia or ‘chest infection’.
Changes in disease labelling practice might partly account for these trends.
• What is the key question?
Recent evidence suggests an increasing trend in pneumonia hospitalizations. This study ana-
lysed primary care electronic health records for more than 70 million patient years of follow-
up to evaluate whether pneumonia incidence had increased in community settings.
• What is the bottom line?
Clinically-diagnosed pneumonia increased from 2002 to 2017, with an acceleration in trend
after 2011. There was a simultaneous decrease in the more frequent diagnosis of clinically-
suspected pneumonia characterized as antibiotic-treated chest infection. This suggests that
changes in diagnostic labelling may at least in part account for the apparent increase in
clinically-diagnosed pneumonia.
• Why read on?
The large study, including practices from throughout the UK, sheds new light on previous
reports of increasing pneumonia hospitalisations. The study shows that in adults there have
been divergent trends in different respiratory infection diagnoses with increasing clinically-
diagnosed pneumonia and reducing clinically-suspected pneumonia. This is in contrast to
consistently decreasing lower respiratory infections in children.
Introduction
With the advent of antibiotics, common but severe infections such as pneumonia could be
effectively cured with access to effective antimicrobial treatment [1] but community acquired
pneumonia (CAP) remains a major public health priority worldwide, disproportionally affect-
ing younger and older populations [2–4]. As an ambulatory care sensitive condition, [5] pneu-
monia may be managed in primary care or may result in hospital admission, depending on
assessment of severity [6]. Recently, increasing hospital admissions for pneumonia have
been reported in several studies [2, 7, 8]. In the USA, Fry et al. [2] reported increasing pneu-
monia hospitalisation rates in people aged 65 years and older and suggested that increasing
comorbidity might be a contributing factor. In England, analysis of hospital episode statistics
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showed increasing hospital admissions for pneumonia from 1997
to 2005 [7]. The increase did not appear to be fully explained by
demographic change, nor by an increase in co-existing conditions
[7]. In Oxfordshire, hospital admissions for CAP increased from
1998 to 2014, with a more rapid rate of increase after 2008 [8].
Trends were similar in all age groups [8]. Other studies also sug-
gest that the rate of emergency hospital admissions for pneumo-
nia is increasing [9, 10].
While accumulating evidence points to a growing burden of
pneumonia on hospital services, this may not necessarily mean
that the incidence of pneumonia disease is increasing in the gen-
eral population. Patients with pneumonia treated in hospital set-
tings may differ from those managed in community. The decision
to admit to hospital may depend on a patient’s general health
condition and social circumstances, as well as severity of illness
[11]. Pneumonia may complicate pre-existing illnesses that
make individuals vulnerable to infectious pathogens [12, 13].
Pneumonia itself may contribute to deterioration in underlying
or pre-existing medical conditions including heart failure [14]
or coronary syndromes [15] for which hospitalisation may be
indicated. Investigation of the epidemiology of respiratory
syndromes in the community is therefore indicated.
In primary care, management of respiratory conditions may
often be ‘symptom oriented’. Definitive diagnosis thorough con-
firmatory tests may be less readily available in comparison with
secondary care. Family physicians in the UK use the Snomed
CT [16] and Read Code classifications [17], which enable coding
of comprehensive and detailed patient information including
occupation, social circumstances, clinical symptoms and signs,
clinical tests and use of medical services [16]. This is in contrast
to the disease categorisations offered by the International
Classification of Diseases (ICD) [18] used for coding of hospital
episode statistics. Primary care classifications provide detailed
and granular coding systems including a wider range of informa-
tion to enable patient management in the community. In primary
care, CAP cases may often be identified based on clinical features
rather than from clinical investigations including radiology find-
ings and bacteriological tests [11]. Less specific labels including
‘chest infection’ may be applied to clinically suspected pneumonia
consultations. Clinical guidelines in the UK emphasise that the
category of ‘chest infection’ may contain two general clinical scen-
arios: acute bronchitis and CAP, with antibiotics only being indi-
cated for the latter [19]. Conversely, there may be no major
differences between management recommendations for CAP
and clinically suspected pneumonia labelled as ‘chest infection’
in terms of essential elements of treatment, severity assessment
and referral principles in adult population [6, 19]. From a disease
management perspective, adult CAP and antibiotic-treated chest
infection cases might be labelled interchangeably during consulta-
tions in primary care.
To provide complementary information to hospital-based
studies, this study aims to evaluate trends in the incidence of con-
ditions managed as pneumonia in the community. In this study,
CAP was included as ‘clinically diagnosed pneumonia’ whereas
antibiotic-treated chest infection as ‘clinically suspected pneumo-
nia’. Influenza pneumonia was included to assess whether second-
ary pneumonia complicating influenza has exerted a significant
impact on pneumonia burden in the community [20, 21].
Pleural infection was also analysed because it shares a similar aeti-
ology to pneumonia and may be associated with pneumonia
severity, with recent studies documenting increasing pleural infec-
tion trends especially among children [22].
Methods
Data source and study design
A population-based cohort study was conducted in the UK
Clinical Practice Research Datalink (CPRD). The CPRD is the
world’s largest database of primary care electronic health records,
covering approximately 7% of the UK family practices [23]. More
than 98% of the UK population were registered with a family
practice [24]. The CPRD population is considered to be represen-
tative of the UK population; the database includes comprehensive
data for drug prescriptions and diagnoses recorded in primary
care, which have been shown to be valid in many studies [23,
24]. The CPRD comprises an open cohort of UK family practices
and their registered patients. The present analysis included all eli-
gible family practices contributing to CPRD, and data for all regis-
tered patients aged up to 100 years old, during 16 calendar years
from the beginning of 2002 to the end of 2017.
Cases
We included recorded diagnoses of pneumonia, antibiotic-treated
chest infection, influenza pneumonia and pleural infection, includ-
ing bacterial pleurisy and empyema. Read codes were reviewed and
selected independently by two researchers with clinical and epi-
demiological backgrounds. Pneumonia was defined using Read
codes associated with ‘pneumonia’ terms after excluding tubercu-
losis (TB), fungal and parasite pneumonia. Influenza pneumonia
was evaluated as a separate group. The remaining pneumonia
codes were grouped into a single category of ‘bacterial pneumonia’
after excluding non-infectious pneumonia codes e.g. bronchiolitis
obliterans organising pneumonia [25]. This was consistent with
the category of CAP being mainly used to refer to uncomplicated
bacterial pneumonia in the general population. CAP was
evaluated as ‘clinically diagnosed pneumonia’ in this study.
Antibiotic-treated chest infection cases were identified when
patients were recorded with ‘chest infections’ and received anti-
biotic prescription on the same day. ‘Antibiotics’ included antibac-
terial agents from chapter 5.1 of the British National Formulary
without anti-viral, anti-TB, anti-leprosy and anti-fungal drugs
[26]. Antibiotic-treated chest infection was then analysed as clinic-
ally suspected pneumonia. Empyema and bacterial pleurisy were
analysed as pleural infection. Primary diagnoses were not differen-
tiated when multiple diagnoses were recorded in a single consult-
ation. Codes for the same condition in the same patient during a
90-day time-window were considered to represent a single episode.
Statistical analysis
Person-time at risk was estimated for the CPRD registered popula-
tion by year from 2002 to 2017 as a denominator. For each patient,
we included time from the latest of the patient registration date, or
the date the family practice began contributing data to CPRD, to the
earliest of the patient end-of-registration, death date or the date the
practice left CPRD. Incident events were considered as those
recorded more than 1 year after the patient start-date to eliminate
prevalent cases from any possible duplication of records during
patient registration. Age-specific incidence rates were calculated
using the age-groups 0–4 years, 5–14 years, then 10-year age-groups,
up to 85 years and older. Data for participants aged more than 100
years were omitted as these are few in number and may be subject to
data recording errors. Age- and sex-standardised incidence rates
(ASRs) were calculated using the European standard population
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(2013 revision). To evaluate whether there had been any recent
changes in trend, changes over calendar year were modelled by join-
point regression analysis [27] using Joinpoint Trend Analysis soft-
ware from the NIH National Cancer Institute [28]. The joinpoint
method starts with a linear model and tests whether addition of
joinpoints improves goodness of fit using Monte-Carlo permutation
tests [27]. Annual percentage changes (APCs) were estimated to
quantify the direction and slope of the trend in given period of
time and average annual percent change (AAPC) was adopted to
measure average rate changes across the whole study period.
Sensitivity analyses
To evaluate whether changes in the family practice population
influenced conclusions, we repeated analyses including only the
218 family practices that contributed data in each year of study
from 2002 to 2017.
Research ethics
The research protocol for this study was submitted to and
approved by the Medicines and Healthcare Products Regulatory
Agency (MHRA) Independent Scientific Advisory Committee
(ISAC), Protocol 16_020. All patient medical records were anon-
ymised before data received by researchers.
Results
There were 550 family practices contributing to CPRD in 2002,
increasing to 631 in 2007, before declining to 314 in 2017
(Table 1). There was a total of 4.2 million person-years of
follow-up of registered patients aged up to 100 years in 2002,
increasing to 5.03 million in 2008–2009, before declining to 2.5
million in 2017.
Clinically diagnosed pneumonia
The number of episodes of clinically diagnosed pneumonia was
between 5000 and 10 000 in each year of study (Table 1). Six
codes accounted for 81% of all pneumonia episodes: ‘pneumonia
due to unspecified organism’ (38%); ‘bronchopneumonia due to
unspecified organism’ (14%); ‘history of pneumonia’ (12%); ‘com-
munity acquired pneumonia’ (8%); ‘lobar (pneumococcal) pneu-
monia’ (7%) and ‘lobar pneumonia due to unspecified organism’
(3%). The crude incidence rate of clinically diagnosed pneumonia
increased from 1.50 (1.46–1.54) per 1000 patient years in 2002 to
1.64 (1.60–1.68) per 1000 in 2010, the rate then increased more
rapidly to 2.22 (2.16–2.28) per 1000 in 2017. Figure 1 (top left
panel) shows changes in the age-standardised rates of pneumonia
for men and women separately with fitted lines from joinpoint
regression. Trends were similar in men and women but clinically
diagnosed pneumonia was more frequent in men. Table 2 pre-
sents estimates from the joinpoint regression model. The APC
in age-standardised rate of clinically diagnosed pneumonia was
0.3% (95% confidence interval −0.6 to 1.2) per year from 2002
to 2010 but from 2010 to 2017 the APC was 5.1% (3.4–6.9) per
year. The AAPC over the entire period was 2.4% (3.4–6.2) per
year. Estimation of age-specific rates of pneumonia (Fig. 2)
shows that clinically diagnosed pneumonia was reducing through-
out the period in children aged under 15 years, while recorded
Table 1. Number of incidence events of pneumonia and related conditions
Year Family practices Person years
Clinically
diagnosed
pneumonia
Clinically suspected
pneumonia
Influenza
pneumonia Pleural infection
Freq. Ratea Freq. Ratea Freq. Ratea Freq. Ratea
2002 550 4 191 630 6291 1.50 99 256 23.68 956 0.23 136 0.03
2003 586 4 458 959 7189 1.61 116 781 26.19 1081 0.24 157 0.04
2004 612 4 767 931 7219 1.51 117 265 24.59 1264 0.27 157 0.03
2005 620 4 898 961 8184 1.67 139 785 28.53 1473 0.30 186 0.04
2006 626 4 956 288 7812 1.58 134 030 27.04 1454 0.29 192 0.04
2007 631 5 016 169 7798 1.55 151 411 30.18 1468 0.29 200 0.04
2008 627 5 025 191 8043 1.60 152 922 30.43 1500 0.30 207 0.04
2009 621 5 026 729 7977 1.59 133 848 26.63 6103 1.21 215 0.04
2010 613 4 967 771 8145 1.64 136 905 27.56 2110 0.42 210 0.04
2011 596 4 862 957 8141 1.67 127 963 26.31 1574 0.32 177 0.04
2012 580 4 805 309 8529 1.77 133 994 27.88 1309 0.27 196 0.04
2013 564 4 595 318 8376 1.82 112 730 24.53 1025 0.22 177 0.04
2014 530 4 201 387 7802 1.86 96 219 22.90 859 0.20 134 0.03
2015 462 3 605 006 7353 2.04 76 108 21.11 672 0.19 107 0.03
2016 371 2 861 175 6346 2.22 57 126 19.97 536 0.19 102 0.04
2017 314 2 455 307 5457 2.22 44 662 18.19 430 0.18 91 0.04
Figures are frequencies except where indicated.
aRate per 1000 person years.
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clinically diagnosed pneumonia increased in adults, especially at
older ages. In patients aged 15–54 years, rates of clinically diag-
nosed pneumonia were slightly higher in women than men but,
but over the age of 55 years clinically diagnosed pneumonia
was more frequent in men, especially at the oldest ages.
Clinically suspected pneumonia
The annual number of cases of clinically suspected pneumonia
ranged between 44 662 and 152 992. Two codes accounted for
more than 99% of clinically suspected pneumonia: ‘chest infection
not otherwise specified’ (61%) and ‘chest infection’ (39%). The
crude rate of clinically suspected pneumonia was more than 10
times higher than for clinically diagnosed pneumonia, increasing
from 23.7 in 2002 to 30.4 per 1000 in 2008 before declining to
18.2 per 1000 in 2017 (Table 1). Figure 1 (top right panel)
shows that trends age-standardised rates of clinically suspected
pneumonia were similar in men and women, but absolute rates
were greater in women than in men. Joinpoint regression indicated
a change in trend in 2008. The APC from 2002 to 2008 was 3.8%
(0.8–6.9) per year compared with −4.9% (−6.7 to −3.1) per year
after 2008. Changes in age-specific rates were generally consistent
but clinically suspected pneumonia was more frequent in women
from 15 to 74 years but more frequent in males during child-
hood and over the age of 75 years. The overall trend for all
chest infection diagnoses was similar to clinically suspected
pneumonia with the same turning point of 2008. While the pro-
portions of all chest infections that were clinically suspected
pneumonia increased steadily from 66% in 2002 to 88% in
2017 at an average APC of 1.6% (1.4–1.8) per year, suggesting
Fig. 1. Trends in pneumonia and related conditions for both men (blue) and women (red) 2002–2017. Rates are per 1000 person-years.
Table 2. Joinpoint regression estimates for APC
Condition Measure
Year of
joinpoint
APC (%) before joinpoint
(95% CI)
APC (%) after joinpoint
(95% CI)
Average APC (%) 2002 to
2017 (95% CI)
Clinically diagnosed
pneumonia
Crude-rate 2010 0.4 (−0.7 to 1.5) 4.8 (3.4–6.2) 2.4 (3.4–6.2)
ASR 2011 0.3 (−0.6 to 1.2) 5.1 (3.4–6.9) 2.2 (1.4–3.0)
Clinically suspected
pneumonia
Crude-rate 2008 3.9 (0.9–7.1) −4.7 (−6.6 to −2.9) −1.4 (−2.8 to 0.1)
ASR 2008 3.8 (0.8–6.9) −4.9 (−6.7 to −3.1) −1.5 (−2.9 to −0.1)
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that ‘chest infection’ not treated with antibiotics declined more
rapidly than treated chest infection.
Influenza pneumonia and pleural infection
Table 1 and Figure 1 present data for influenza pneumonia and
pleural infection (including bacterial pleurisy and empyema).
Rates of influenza pneumonia showed a peak in 2009 but
remained low in other years. Rates of pleural infection were low
and showed no consistent trend over time. Pleural infection was
more frequent in men than women but there was no gender dif-
ference for influenza pneumonia.
Sensitivity analysis
To evaluate whether attrition of family practices from CPRD,
accounted for changes in coding, analyses were repeated using
only data from 218 family practices that contributed data in
every year from 2002 to 2017. In these 218 practices, the crude
rate of clinically diagnosed pneumonia increased from 1.38 per
1000 in 2002 to 1.56 per 1000 in 2010 and then increased to
2.24 per 1000 in 2017 with an APC being 3.1% (1.9–4.2). For clin-
ically suspected pneumonia, the crude rate increased from 20.8
per 1000 in 2002 to 29.7 per 1000 in 2008 at an APC of 4.0%
(0.9–7.2) before declining to 18.0 per 1000 in 2017 at an average
percentage of 5.1% (−6.6% to −3.4).
Discussion
Main findings
There was an increasing trend in clinically diagnosed pneumonia
from 2002 onwards and this accelerated after 2011. This was
unlikely to be due population ageing because similar trends
were observed for age-standardised and crude incidence rates.
Analysis of clinically suspected pneumonia showed that this syn-
drome was much more frequently recorded than clinically diag-
nosed pneumonia and incidence rates increased from 2002 to
2008 but decreased rapidly thereafter. Clinicians necessarily
work with diagnostic disease classifications but pulmonary infec-
tions may represent graduated phenomena with varying degrees
of bronchial inflammation an alveolar consolidation. This may
contribute to diagnostic uncertainties and perhaps inconsistent
selection of diagnostic terms. Given that ‘chest infection’ may
not be a confident diagnosis, together with the volume of
antibiotic-treated chest infection rates being considerably higher
than that of diagnosed pneumonia, a small change in disease cod-
ing practice could lead to a shift from ‘chest infection’ recording
to ‘pneumonia’ recording. Joinpoint regression analysis suggested
that the decline in ‘chest infection’ recording began in 2008
slightly before the increase in ‘pneumonia’ recording from 2011.
However, conditions managed as pneumonia were considered as
relatively stable as none of the AAPCs have shown to be statistic-
ally significant from middle age and above. This would suggest
that there was code drifting during clinical consultations when
Fig. 2. Age-specific rates for clinically diagnosed pneumonia and clinically suspected pneumonia for males (blue) and females (red). Rates are per 1000
person-years.
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pneumonic infectious symptoms were presented among adult
population with elder patient being more likely being diagnosed
with pneumonia.
According to UK guidelines, adult ‘chest infection’ should
be managed as CAP when pneumonia is suspected [20].
However, Petersen et al. [29] regarded pneumonia as a poten-
tial complication of chest infection in their electronic health
records based study. If antibiotics are prescribed less frequently
for chest infection it is possible that pneumonia might increase
[30]. One study suggested that pneumonia might be more fre-
quent at family practices that prescribe fewer antibiotics for
respiratory infections [30]. Thus although it appears likely
that changes in coding of respiratory infections account for
observed trends, the present data do not exclude the possibility
that changing management of ‘chest infections’ is leading to an
increase in pneumonia incidence. Therefore, understanding the
underlying reason for adopting certain disease labels such as
‘chest infection’ rather than confident disease diagnoses during
routine healthcare in the community would contribute to
understanding the challenges of diagnostic uncertainty in pri-
mary care settings.
In children, records of both clinically diagnosed pneumonia
and clinically suspected pneumonia decreased. This could be
explained by the introduction of Haemophilus Influenzae Type
B vaccine in 1992 and pneumococcal conjugate 7 vaccine in
2006 into the UK childhood immunisation scheme [31]. In adults,
rates of clinically diagnosed pneumonia increased while clinically
suspected pneumonia decreased. Trends were generally similar in
males and females but women between the ages of 15 and 74
years were more likely to be recorded with antibiotic-treated
chest infection than men, but this distinction was not apparent
for clinically diagnosed pneumonia. It is unclear whether this
represents a disease classification preference or whether more
severe cases tended to be found in men. Influenza pneumonia
showed an increase in the epidemic year of 2009 [21] but overall
low incidence of influenza pneumonia might result from the
influenza vaccination schemes among both young and elder
populations [31]. Pleural infection was analysed as a surrogate
of severe pneumonia because recent evidence suggests an increase
in incidence rate trends among children [22]. Our results showed
that the incidence trends for pleural infection remained stable
during the past 16 years.
Comparison with previous studies
In contrast to previous studies on pneumonia burden using
hospital admission data [7, 8], this study using electronic
health records data with general practitioners being data
recorders. Since pneumonia patients referred to secondary
care may not necessarily be representative of all CAP, using
primary care consultation data contributes to understanding
pneumonia patients presenting and managed in primary care
settings.
In National Institute for Health and Care Excellence (NICE)
guidelines for both CAP and chest infection, together with
British Thoracic Society recommendations for CAP management
in adult patients, CRB-65 score (confusion, raised respiratory rate,
low blood pressure and age 65 and above) is recommended to
guide risk assessment and place of treatment [6, 19, 32]. This
score identifies older age (⩾65 years old) as an independent
risk score since being 65 years and above will automatically clas-
sify patients into an intermediate-risk group. This implies that
more conservative management strategies have been applied to
older pneumonia patients. This partially explained previous
study findings that pneumonia patients in the community leading
to hospitalisation were increasing in recent years among elder
populations and there is no evidence that less severe patients
were admitted to secondary care.
Strengths and limitations
This population-based study analysed healthcare records to out-
line the range of conditions that were managed as pneumonia in
the community. The 16-year timeframe provided sufficient data
to estimate disease trends over a substantial study period. The
study included all eligible practices and patients contributing
health care information to CPRD more than 1 year. There
were 320 practices participating the database by the end of
2017. Previous studies have shown the completeness and data
of high quality in CPRD. The large sample size of research
cohort was sufficient for depicting the trends for clinically diag-
nosed pneumonia, clinically suspected pneumonia, even low
incidence conditions such as influenza pneumonia and pleural
infections.
CPRD has not released free text information since 2013, which
would enable us to examine diagnostic information documented
in free text records rather than coded. But, we consider that clin-
icians would record relevant conditions such as pneumonia or
chest infection especially when clinical discretion leads to anti-
biotic treatment. Also, health care information in CPRD made
disease severity assessment unfeasible, therefore, we could not
confidently determine whether case severity influenced coding
practices or place of treatment. Also, we did not capture data
from out-of-hour services, walk-in centre consultations and emer-
gency care.
This study was derived from a universal health care coverage
system where most common conditions are managed in primary
care settings, implications generated from this study would
mainly apply to similar systems but not where health care insur-
ance plays an essential role or referral thresholds from primary
care to secondary care vary extensively compared with that in
the UK.
Conclusion
Clinically diagnosed pneumonia is increasing over time in the
UK. This trend could not be fully explained by ageing population,
changes in coding practice or alternative diagnosis. Age-specific
trends were divergent with decreasing trends in children but
increasing in older adults. Respiratory conditions managed as
pneumonia in family practice were decreasing slightly over time,
which was more likely due to more conservative antibiotic pre-
scribing strategies. Research to reduce diagnostic uncertainty
would contribute to improving antibiotic stewardship in the
community.
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